To date, some genetic biomarkers have been reported to be associated with the pathogenesis of PD [12]; such as α-synuclein, glucocerebrosidase, leucine-rich repeat kinase 2, and synaptojanin 1, can be useful to diagnose or assess the risk of PD [10]. This evidence concerns the gene SYNJ1 and Parkinson disease.